Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings ...
read more
IQVIA™, a global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, has been recognized along with the National Basketball Association and partners at Harvard, Columbia and BioReference ...
read more
Wednesday, February 11, 2026
IQVIA and the Duke Clinical Research Institute (DCRI) announced a collaboration to enhance the conduct of clinical research in obesity and related cardiometabolic trials.
read more
Thursday, February 21, 2019
IQVIA has announced the appointment of Carol J. Burt to its board of directors, effective immediately.
read more
Ipsen announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by researchers in MD Anderson’s Institute for Applied Cancer Science (IACS).
read more
Thursday, November 19, 2015
Ipsen, a global specialty driven pharmaceutical group, and Interprotein Corporation, a Japanese R&D focused biotechnology company, have signed a research collaboration and an option agreement to develop and commercialize new therapeutic peptides ...
read more
Wednesday, October 20, 2021
IPS-Integrated Project Services, LLC, headquartered in Blue Bell, Pennsylvania and a subsidiary of Alleghany Capital Corporation, today announced that it has acquired Linesight, a multinational consulting firm headquartered in Dublin, Ireland. IPS is...
read more
Deloitte has announced its acquisition of Iperion Life Sciences Consultancy.
read more
IPA announced the identification of numerous lead candidate antibodies with highly-potent neutralizing activity in vitro, which are being manufactured for further testing and possible inclusion in the Company's PolyTope™ mAb Therapy to combat the ...
read more
Iovance Biotherapeutics has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU).
read more
Wednesday, March 10, 2021
IONTAS and FairJourney Biologics have announced that they have entered into an agreement with Quell Therapeutics regarding IONTAS / FJB’s proprietary libraries and technology platforms.
read more
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, announced that F-star Therapeutics dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.
read more
Wednesday, February 02, 2022
IonsGate Preclinical Services Inc InSilicoTrials have announced a partnership to leverage innovative technology like Modeling and Simulation.
read more
IonSense and WHALE Biolabs announced a strategic alliance to provide analytical services for chemists utilizing HTE in their laboratories.
read more
Tuesday, October 13, 2020
IonSense has announced the first shipments of their next-generation JumpShot Technology enabled DART source.
read more